Foxa1 and Foxa2 regulate β-cell differentiation, glucagon biosynthesis, and secretion

Endocrinology (United States)

Volumn 155, Issue 10, 2014, Pages 3781-3792

  Masson, Mounia Heddad ^a   Poisson, Caroline ^a   Guérardel, Audrey ^a   Mamin, Aline ^a   Philippe, Jacques ^a   Gosmain, Yvan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLUCAGON; GLUCOSE TRANSPORTER 1; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MESSENGER RNA; PROGLUCAGON; SMALL INTERFERING RNA; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR NKX2.2; FOXA1 PROTEIN, RAT; FOXA2 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BHK CELL LINE; BINDING SITE; BIOSYNTHESIS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; GENETIC TRANSCRIPTION; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; HAMSTER; HORMONE SYNTHESIS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET CELL FUNCTION; PRIMARY CELL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENETICS; MALE; PHYSIOLOGY; RAT; SECRETION (PROCESS);

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELLS, CULTURED; CRICETINAE; GLUCAGON; GLUCAGON-SECRETING CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-BETA; MALE; PROMOTER REGIONS, GENETIC; RATS; RNA, SMALL INTERFERING;

EID: 84907223887     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1843     Document Type: Article

References (46)

1. Gromada J, Franklin I, Wollheim CB. Cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007;28:84-116.
2. Dunning BE, Foley JE, Ahren B. Cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia. 2005;48: 1700-1713.
3. Kaestner KH, Katz J, Liu Y, Drucker DJ, Schutz G. Inactivation of the winged helix transcription factor HNF3 affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 1999;13:495-504.
4. Lee CS, Sund NJ, Behr R, Herrera PL, Kaestner KH. Foxa2 is required for the differentiation of pancreatic-cells. Dev Biol. 2005; 278:484-495.
5. Gao N, LeLay J, Vatamaniuk MZ, Rieck S, Friedman JR, Kaestner KH. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 2008;22:3435-3448.
6. Shih DQ, Navas MA, Kuwajima S, Duncan SA, Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3-deficient mice. Proc Natl Acad Sci USA. 1999;96:10152-10157.
7. Vatamaniuk MZ, Gupta RK, Lantz KA, Doliba NM, Matschinsky FM, Kaestner KH. Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. Diabetes. 2006;55:2730-2736.
8. Sund NJ, Vatamaniuk MZ, Casey M, et al. Tissue-specific deletion of Foxa2 in pancreatic cells results in hyperinsulinemic hypoglycemia. Genes Dev. 2001;15:1706-1715.
9. Gao N, White P, Doliba N, Golson ML, Matschinsky FM, Kaestner KH. Foxa2 controls vesicle docking and insulin secretion in mature cells. Cell Metab. 2007;6:267-279.
10. Kaestner KH, Hiemisch H, Schutz G. Targeted disruption of the gene encoding hepatocyte nuclear factor 3 results in reduced transcription of hepatocyte-specific genes. Mol Cell Biol. 1998;18: 4245-4251.
11. Gauthier BR, Schwitzgebel VM, Zaiko M, Mamin A, Ritz-Laser B, Philippe J. Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements. Mol Endocrinol. 2002;16:170-183.
12. Gosmain Y, Avril I, Mamin A, Philippe J. Pax-6 and c-Maf functionally interact with the-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J Biol Chem. 2007;282:35024-35034.
13. Gao N, Le Lay J, Qin W, et al. Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature-cell. Mol Endocrinol. 2010;24:1594-1604.
14. Gosmain Y, Marthinet E, Cheyssac C, et al. Pax6 controls the expression of critical genes involved in pancreatic cell differentiation and function. J Biol Chem. 2010;285:33381-33393.
15. Gosmain Y, Katz LS, Masson MH, Cheyssac C, Poisson C, Philippe J. Pax6 is crucial for-cell function, insulin biosynthesis, and glucose-induced insulin secretion. Mol Endocrinol. 2012;26:696-709.
16. Cordier-Bussat M, Morel C, Philippe J. Homologous DNA sequences and cellular factors are implicated in the control of glucagon and insulin gene expression. Mol Cell Biol. 1995;15:3904-3916.
17. Watada H, Scheel DW, Leung J, German MS. Distinct gene expression programs function in progenitor and mature islet cells. J Biol Chem. 2003;278:17130-17140.
18. Lantz KA, VatamaniukMZ,Brestelli JE, Friedman JR, Matschinsky FM, Kaestner KH. Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest. 2004;114:512-520.
19. Sharma SK, Leinemann U, Ratke R, et al. Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans. Biochem J. 2005; 389:831-841.
20. Le Marchand SJ, Piston DW. Glucose suppression of glucagon secretion: metabolic and calcium responses from-cells in intact mouse pancreatic islets. J Biol Chem. 285:14389-14398.
21. Quesada I, Tuduri E, Ripoll C, Nadal A. Physiology of the pancreatic-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199:5-19.
22. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000;85:4053-4059.
23. Taborsky GJ Jr, Ahren B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired-cell responses in type 1 diabetes. Diabetes. 1998;47:995-1005.
24. Kaestner KH. The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab. 2000;11:281-285.
25. Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns. 2004;5:193-208.
26. Kaestner KH, Lee CS, Scearce LM, et al. Transcriptional program of the endocrine pancreas in mice and humans. Diabetes. 2003;52: 1604-1610.
27. Ye DZ, Kaestner KH. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L-and D-cells in mice. Gastroenterology. 2009;137:2052-2062.
28. Wolfrum C, Besser D, Luca E, Stoffel M. Insulin regulates the activity of forkhead transcription factor Hnf-3/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci USA. 2003;100:11624-11629.
29. von Meyenn F, Porstmann T, Gasser E, et al. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab. 17:436-447.
30. Artner I, Blanchi B, Raum JC, et al. MafB is required for islet cell maturation. Proc Natl Acad Sci USA. 2007;104:3853-3858.
31. Nishimura W, Kondo T, Salameh T, et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic-cells. Dev Biol. 2006;293:526-539.
32. Nishimura W, Rowan S, Salameh T, et al. Preferential reduction of cells derived from Pax6-MafB pathway in MafB deficient mice. Dev Biol. 2008;314:443-456.
33. Hussain MA, Lee J, Miller CP, Habener JF. POU domain transcription factor brain 4 confers pancreatic-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Mol Cell Biol. 1997;17:7186-7194.
34. Heller RS, Stoffers DA, Liu A, et al. The role of Brn4/Pou3f4 and Pax6 in forming the pancreatic glucagon cell identity. Dev Biol. 2004;268:123-134.
35. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic cells. Development. 1998; 125:2213-2221.
36. Ahlgren U, Pfaff SL, Jessell TM, Edlund T, Edlund H. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature. 1997;385:257-260.
37. Tomaru Y, Nakanishi M, Miura H, et al. Identification of an intertranscription factor regulatory network in human hepatoma cells by Matrix RNAi. Nucleic Acids Res. 2009;37:1049-1060.
38. Wang M, Drucker DJ. The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem. 1995;270:12646-12652.
39. Artner I, Le Lay J, Hang Y, et al. MafB: an activator of the glucagon gene expressed in developing islet-and-cells. Diabetes. 2006; 55:297-304.
40. Rouille Y, Martin S, Steiner DF. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J Biol Chem. 1995;270:26488-26496.
41. Furuta M, Zhou A, Webb G, et al. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem. 2001;276:27197-27202.
42. MacDonald PE, De Marinis YZ, Ramracheya R, et al. A K ATP channel-dependent pathway within cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol. 2007;5:e143.
43. Tschritter O, Stumvoll M, Machicao F, et al. The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes. 2002;51:2854-2860.
44. Gromada J, Ma X, Hoy M, et al. ATP-sensitive K channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1/mouse-cells. Diabetes 53 Suppl. 2004; 3:S181-S189.
45. Gosmain Y, Cheyssac C, Masson MH, Guerardel A, Poisson C, Philippe J. Pax6 is a key component of regulated glucagon secretion. Endocrinology 153:4204-4215.
46. Meier JJ, Gallwitz B, Siepmann N, et al. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetologia. 2003;46: 798-801.